Clinical and Epidemiological Features of Pediatric Patients with COVID-19 in a Tertiary Pediatric Hospital
Keywords:
COVID-19, children, SARS-CoV-2 infection, comorbidities, eosinopeniaAbstract
Background: Coronavirus disease 2019 (COVID-19) affects people of any age with high mortality and morbidity in adults older than 65 years. Reports on pediatric cases highlighted those children generally develop milder symptoms than adults or are asymptomatic. We aimed to assess the epidemiological and clinical data of children and adolescents with SARS-CoV-2 infection to improve pediatric COVID-19.
Methods: We retrospectively analyzed clinical and epidemiological features of patients with SARS-CoV-2 infection hospitalized at the Pediatric Hospital of Pavia, Italy, between February 1, 2020, to April 30, 2021.
Results: 71 patients aged 0-16 years were included; 33 (46%) females and 38 (54 %) males. Thirty-three (46%) patients had comorbidities, such as obesity and hematological diseases. Thirty-one children (44%) were exposed to COVID-19-positive household members. Nine (12.7 %) patients were asymptomatic, whereas 57 (80.3%) had a mild-moderate disease. Only five (7%) showed a severe or critical disease, and two patients required ICU admission. The most frequent symptoms were fever (76%), loss of appetite (26%), gastrointestinal symptoms (19%), and cough (19%). Chest X-ray was performed in 42 patients showing lung abnormalities in more than half of symptomatic patients. The most common laboratory features were lymphopenia and eosinopenia associated with high levels of inflammation markers.
Conclusions: This study confirmed that COVID-19 has a mild course in children compared to adults. Most of the enrolled children were asymptomatic or had a mild-moderate disease. Patients with comorbidities were more prone to develop clinical complications.
References
Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020;92(4):401–2.
WHO. Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. [cited 2021 Apr 25]. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it
Novelli V, Cutti S, Muzzi A Timely adaptation of a Pediatric Unit to COVID-19 emergency in Northern Italy: the experience of Fondazione IRCCS Policlinico San Matteo in Pavia. Acta Biomed. 2020 Sep 15;91(11-S):e2020004.
Hu B, Guo H, Zhou P. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol [Internet]. 2021 [cited 2021 Apr 29]; Available from: www.nature.com/nrmicro
Wiersinga WJ, Rhodes A, Cheng AC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA - J Am Med Assoc. 2020;324(8):782–93.
Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. Jama. 2020;323(14):1335.
Parri N, Lenge M, Buonsenso D. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020 July 9;383(2):187–90.
Castagnoli R, Votto M, Licari A. Severe Acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children and adolescents: A systematic review. JAMA Pediatr. 2020;174(9):882–9.
Boechat JL, Wandalsen GF, Kuschnir FC. COVID-19 and pediatric asthma: Clinical and management challenges. Int J Environ Res Public Health. 2021;18(3):1–19.
Brodin P. Why is COVID-19 so mild in children? Acta Paediatr Int J Paediatr. 2020;109(6):1082–3.
Dong Y, Mo X, Hu Y. Epidemiology of COVID-19 Among Children in China. Pediatrics [Internet]. 2020 [cited 2021 Apr 20];145(6):20200702.
Cruz AT, Zeichner SL. COVID-19 in Children: Initial Characterization of the Pediatric Disease. Pediatrics [Internet]. 2020 [cited 2021 April 20]
Larenas-Linnemann D, Luna-Pech J, Navarrete-Rodríguez EM. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group. Vol. 21, Current Allergy and Asthma Reports. 2021.
Verdoni L, Mazza A, Gervasoni A. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet [Internet]. 2020 [cited 2021 Apr 23];395.
Riollano-Cruz M, Akkoyun E, Briceno-Brito E. Multisystem inflammatory syndrome in children related to COVID-19: A New York City experience. J Med Virol. 2021;93(1):424–33.
World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19: Scientific Brief 15 May 2020. Who [Internet]. 2020;10(May):1–9. Available from: https://www.who.int/news room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and adolescents-with-covid 19%0Ahttp://www.who.int/newsroom/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
Diotallevi F, Campanati A, Bianchelli T. Skin involvement in SARS-CoV-2 infection: Case series. J Med Virol. 2020;92(11):2332–4.
Talarico V, Pinto L, Marseglia GL. Impact of novel coronavirus Disease-19 (COVID-19) pandemic in Italian pediatric emergency departments: a national survey. Ital J Pediatr. 2021 Mar 3;47(1):47.
Brambilla I, Tosca MA, De Filippo M. Special Issues for Coronavirus Disease 2019 in Children and Adolescents. Obesity (Silver Spring). 2020 Aug;28(8):1369
https://www.aifa.gov.it/-/aifa-approva-il-vaccino-comirnaty-per-la-fascia-di-età-5-11-anni
De Filippo M, Votto M, Brambilla I. Allergy and COVID-19. Acta Biomed. 2021 Nov 29;92(S7):e2021522.
Marseglia G, Ciprandi G. Eosinopenia could be a relevant prognostic biomarker in patients with coronavirus disease 2019. 2020;
De Filippo M, Votto M, Licari A. Novel therapeutic approaches targeting endotypes of severe airway disease. Expert Rev Respir Med. 2021 Oct;15(10):1303-1316.
Sacco K, Castagnoli R, Vakkilainen S.Immunopathological signatures in multisystem inflammatory syndrome in children and pediatric COVID-19. Nat Med. 2022 February 17.
Janet V Diaz, John Appiah, Lisa Askie. Clinical management Living guidance COVID-19. World Heal Organ. 2021;(January).
La Tessa A, Motisi MA, Marseglia GL. Use of remdesivir in children with COVID-19 infection: a quick narrative review. Acta Biomed. 2021 Nov 29;92(S7):e2021524.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Maria De Filippo, Paola Magri, Grazia Bossi, Ilaria Brambilla, Riccardo Castagnoli, Amelia Mascolo, Martina Votto, Amelia Licari, Gian Luigi Marseglia
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
